Cargando…
Toll-Like Receptor 7 Agonist Therapy with Imidazoquinoline Enhances Cancer Cell Death and Increases Lymphocytic Infiltration and Proinflammatory Cytokine Production in Established Tumors of a Renal Cell Carcinoma Mouse Model
Imidazoquinolines are synthetic toll-like receptor 7 and 8 agonists and potent dendritic cell activators with established anticancer activity. Here we test the hypothesis that imidazoquinoline has in vivo efficacy within established renal cell carcinoma (RCC) tumors. Immunocompetent mice bearing syn...
Autores principales: | Kauffman, Eric C., Liu, Huixian, Schwartz, Michael J., Scherr, Douglas S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317372/ https://www.ncbi.nlm.nih.gov/pubmed/22481916 http://dx.doi.org/10.1155/2012/103298 |
Ejemplares similares
-
The Imidazoquinoline Toll-Like Receptor-7/8 Agonist Hybrid-2 Potently Induces Cytokine Production by Human Newborn and Adult Leukocytes
por: Ganapathi, Lakshmi, et al.
Publicado: (2015) -
Potent Adjuvanticity of a Pure TLR7-Agonistic Imidazoquinoline Dendrimer
por: Shukla, Nikunj M., et al.
Publicado: (2012) -
Synthesis and immunopharmacological evaluation of novel TLR7 agonistic triazole tethered imidazoquinolines
por: Avoni, Ayyappa, et al.
Publicado: (2023) -
Epigallocatechin-3-gallate suppresses proinflammatory cytokines and chemokines induced by Toll-like receptor 9 agonists in prostate cancer cells
por: Mukherjee, Sushovita, et al.
Publicado: (2014) -
Flexible modulation of agonist efficacy at the human A(3 )adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000
por: Gao, Zhan-Guo, et al.
Publicado: (2008)